Choosing a Practitioner in India

How to Choose a Functional Medicine Practitioner or Clinic in India

Professional scope matters. So does the reasoning underneath the care: whether the test fits the question, the measurement conditions are controlled, the range is defensible, and the result changes a useful decision.

A title can tell you something important about scope. It cannot tell you whether the test fits the question, the sample was measured properly, the threshold is defensible or the intervention matches the evidence. Those have to be inspected separately.

This guide is therefore not a ranking of the "best" doctors or clinics. It is a method for inspecting the reasoning underneath the offer. You can use it on any practitioner in India, including Biohacking India.

01

Start with what the person is actually claiming to do

A qualification matters because it establishes training, scope or legal responsibility. It is not a universal quality score. Ask what service the person is offering and which parts require a regulated professional.

If someone is acting as a medical doctor in India, verify the underlying medical registration. NMC provides an Indian Medical Register and State Medical Council details.[1]

If someone is not acting as a doctor, do not force them into an unrelated registry. The NCAHP Act applies to professions covered by its Schedule, and the current Ministry portal says its database is enrolment, not professional registration. Verify a regulator or register only when it actually applies to the person's base profession or activity.[2][3]

02

Professional scope and scientific rigor are different questions

Medical registration matters when physician-led diagnosis, prescribing or specialist care is required. A functional-medicine certificate can show additional training. Neither tells you, by itself, whether the practitioner chooses the right test, controls measurement error or uses defensible thresholds and interventions.

IFM makes the scope point itself: functional-medicine certification does not expand what someone's underlying profession or license legally allows them to do.[4]

The reverse matters too. Not being a medical doctor does not prove that someone's research appraisal, biomarker reasoning or testing methodology is weak. Scope should be verified where it applies. Scientific rigor should be inspected directly.

03

Comprehensive testing is not the same thing as indiscriminate testing

Biohacking India deliberately starts with broad foundational bloodwork. Our current consultation framework reviews more than 190 biomarkers. I do not want to hide that while telling you to be skeptical of unnecessary testing.

The number of markers is not the quality criterion. A large foundational panel still has to earn its breadth marker by marker. A smaller specialty panel can still be poor if its measurements do not validly answer the question being asked.

The distinction I care about is structure. Establish a useful foundation, rank what matters for this person's problem, add deeper tests only when the history or initial data create a reason to do so, and retest what can change the next decision. Broad does not mean every advanced test for every person.

04

Ask whether the test can answer the exact question

Before worrying about how advanced a test sounds, ask three things. Can the method measure the thing reliably? Does the result mean what the practitioner says it means for this problem? Would knowing it change a useful decision? These roughly correspond to analytical validity, clinical validity and clinical utility.

The right test depends on the exact question, specimen, method and timing. An ordinary test can outperform a fashionable one when it answers the question better.

The examples below are specific because "avoid unnecessary testing" is too vague to guide a real decision.

05

The right test can still become a bad data point if the conditions are wrong

Testing does not start when the machine produces a number. Fasting, collection technique, time of day, recent exercise, medicines or supplements, specimen type and sample handling can matter for particular measurements.[13][14]

Our workflow is deliberately strict, but each rule still has to be justified for the analyte. A blanket instruction is not better merely because it is strict.

This is also why I would ask which assay or method is being used when the method materially changes interpretation. If a practitioner wants to interpret small differences, they should care about how the number was produced first.

06

A laboratory reference interval and a clinical decision threshold are not the same thing

A laboratory reference interval usually describes values expected in a defined reference population under a particular measurement system. CLSI EP28 is a standard for establishing and verifying those intervals.[9]

Clinical decisions can use different kinds of thresholds. IFCC explicitly separates the concepts of reference intervals and decision limits. A diagnostic cutoff, an outcome-linked risk threshold and a treatment target can answer different questions from the lab's population interval.[10]

That does not give practitioners permission to invent a tighter "optimal" range. If someone uses staggered bands such as optimal, suboptimal, at-risk or critical, ask what human evidence supports each boundary and what decision changes when a person crosses it. The granularity has to earn its place.

07

NABL matters, but it comes after choosing the right test

NABL accreditation asks whether a laboratory is technically competent for the tests, methods and capabilities in its accredited scope.[11]

It does not tell you whether the test was worth ordering, whether the result is clinically meaningful, whether the interpretation range is appropriate or whether treatment should change.

The order is question, test, preparation and method, laboratory competence, interpretation, then action. Accreditation supports that chain. It does not replace it.

A useful test survives the whole chain, not just the laboratory step.

01 Question

What exact uncertainty are we trying to resolve?

02 Test

Can this measurement answer that question validly?

03 Method

Were specimen, preparation and assay appropriate?

04 Range

Which reference or decision threshold actually applies?

05 Action

What changes because of the result?

08

Ask what has to be done now, what can wait, and what happens if you skip it

A comprehensive foundation can still be cost-conscious if the practitioner can rank the information. Ask which tests are foundational, which are conditional, which are optional and which result would actually alter the plan.

At Biohacking India, comprehensive bloodwork is the foundation. Gut testing, organic acids, amino acids, genetics or other investigations are layered on when the problem and available information justify them. "Advanced" is not the justification. The question answered is.

If budget is limited, the practitioner should be able to tell you what gives the highest decision value first rather than making the most expensive version of the process the only version that makes sense.

09

Good testing is only useful if the intervention logic is equally disciplined

A polished diagnostic story can still end in a weak protocol. Ask about relevant human outcomes, whether the studied dose and form match the recommendation, safety and interactions, and what would trigger a change. A trial on one formulation does not automatically validate a different dose or product with the same ingredient name.

The same standard applies to scope. A practitioner should be comfortable saying when physician diagnosis, prescriptions, emergency care or specialist management belong with someone else. Collaboration is a strength when the problem genuinely crosses professional boundaries.

I trust a process more when it can change its mind. If the result does not fit the hypothesis or the intervention does not help, the next step should be a revised explanation, not a more elaborate story protecting the first one.

10

When two practitioners look impressive online, compare how they make decisions

Different provider models have real strengths. A doctor-led clinic may offer stronger prescribing, escalation and multidisciplinary continuity. A practitioner-led service may offer deeper nutrition, biomarker work or more direct access. Neither tells you how the practitioner behaves when evidence is weak, tests disagree, money is limited or the first hypothesis fails.

That is the level at which I would compare providers. The table below is intentionally harder to game than a list of logos or certificates.

Questions that reveal the process behind the marketing.
Look atStronger answerWhat makes me cautious
ScopeExplains the underlying profession, what is handled directly, and what triggers referral.Uses a title as proof that every part of the service sits within one person's competence.
Test choiceNames the exact question, why this test answers it, and what a positive, negative or normal result changes.Orders a fashionable panel first and explains the purpose after the result arrives.
Method and preparationCares about specimen, assay, timing, preparation and sample handling when they affect interpretation.Treats every number as directly comparable regardless of how it was collected or measured.
RangesSeparates lab reference intervals, validated decision thresholds and evidence-linked risk bands.Calls a tighter range "optimal" without showing where it came from.
CostRanks foundational, conditional and optional work, including what can safely wait.Makes the largest package feel mandatory without explaining the marginal value of each layer.
InterventionsCan show relevant human evidence, dose/form logic, safety constraints and a stop or reassessment rule.Turns every abnormality into another supplement or treatment with no priority order.
ReassessmentDefines what improvement means, what gets retested and what would change the original hypothesis.Explains a failed plan by adding more mechanisms without revisiting the first assumption.
ContinuityMakes follow-up cadence, messaging access, retesting and escalation explicit so you know what support you are actually buying.Uses the language of long-term care when the service is really a one-off interpretation with limited follow-up.
11

Use the same standards on Biohacking India

I am not a medical doctor. My work focuses on diagnostics-driven biomarker interpretation, nutrition, lifestyle, supplements and evidence appraisal within my scope. When physician-led diagnosis, prescriptions, emergency assessment or specialist management are needed, I work alongside or refer to appropriately qualified clinicians.

I use comprehensive foundational testing, so you should ask me to justify it. Our process reviews 190+ biomarkers, controls important pre-test conditions, uses evidence-linked staggered ranges, prioritizes findings, and adds deeper testing when the problem and existing information justify it.

We avoid IgG food-antibody panels and broad hair-mineral interpretations when the claimed clinical use is not defensible. We also use selected gut tests, organic acids, amino acids, genetics and other investigations in some cases. The exact analyte, method, claim and decision have to earn their place.

Our model is analysis- and protocol-intensive, not weekly multidisciplinary medical care. If you need ongoing physician management, prescriptions or frequent clinical follow-up, a doctor-led clinic may fit better.

Use the same checklist on us. If I cannot explain why a test is used, what method matters, where the range comes from and what would change because of the result, my recommendation should not lower the bar.

If you are evaluating us

Read the method first. Then decide whether the consultation fits your problem.

The consultation page explains our foundational testing, pre-test rules, biomarker interpretation, protocol structure, scope and follow-up process. The broader Functional Medicine in India guide explains how we evaluate the model and its evidence.

Practitioners who want to learn the method rather than hire us can explore the Biohacking Mastery Course.

Sources

References

Regulatory sources are used only for the professions and activities they actually cover. Testing and laboratory sources are attached to the specific scientific distinctions they support.

  1. [1]

    National Medical Commission, India

    Indian Medical Register

    Official NMC search interface for doctors registered with State Medical Councils. NMC notes that its data is being updated.

  2. [2]

    India Code / Ministry of Health and Family Welfare

    National Commission for Allied and Healthcare Professions Act, 2021

    Primary legal source for the national framework covering the allied and healthcare professions listed in the Act's Schedule.

  3. [3]

    Ministry of Health and Family Welfare, Government of India

    Allied and Healthcare Professionals Enrolment Portal

    The current official portal says it is a data-collection and enrolment system, not professional registration, while registration regulations are under process.

  4. [4]

    Institute for Functional Medicine

    Functional Medicine Certified Professional certification

    IFM's current certification language makes clear that certification does not expand the legal scope attached to a practitioner's underlying profession or license.

  5. [5]

    National Institute for Health and Care Excellence

    H. pylori testing recommendations

    Recommends carbon-13 urea breath testing, stool antigen testing, or laboratory serology only where local performance has been validated, and advises against office-based serology.

  6. [6]

    American College of Gastroenterology / American Journal of Gastroenterology

    ACG Clinical Guideline: Treatment of Helicobacter pylori Infection

    2024 guideline. Test-of-cure uses appropriately conducted urea breath, fecal antigen or biopsy-based testing after treatment, with timing and medication washout requirements.

  7. [7]

    American Academy of Allergy, Asthma & Immunology

    The myth of IgG food panel testing

    Explains why food IgG panels have not been validated to diagnose food allergy, intolerance or sensitivity and why IgG can reflect normal exposure or tolerance.

  8. [8]

    Agency for Toxic Substances and Disease Registry

    Hair Analysis Panel Discussion: Executive Summary

    Reviews the limited clinical interpretability of hair measurements for most substances, including contamination, reference-range and dose-response problems, while preserving narrow valid exposure uses.

  9. [9]

    Clinical and Laboratory Standards Institute

    EP28: Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory

    Laboratory standard for establishing and verifying reference intervals, including reference populations and preanalytical and analytical considerations.

  10. [10]

    International Federation of Clinical Chemistry and Laboratory Medicine

    Reference Intervals and Decision Limits committee

    IFCC explicitly treats reference intervals and clinical decision limits as related but distinct concepts that require appropriate standardization and use.

  11. [11]

    National Accreditation Board for Testing and Calibration Laboratories, India

    NABL frequently asked questions on laboratory accreditation and scope

    Explains ISO 15189 medical-laboratory accreditation and that the specific tests, methods and capabilities for which a laboratory is competent are listed in its scope of accreditation.

  12. [12]

    U.S. Food and Drug Administration

    Biotin Interference with Troponin Lab Tests

    FDA warning that biotin can interfere with certain assays and produce incorrect results.

  13. [13]

    Clinical and Laboratory Standards Institute

    PRE02: Collection of Diagnostic Venous Blood Specimens

    2025 CLSI standard for diagnostic venous blood-specimen collection.

  14. [14]

    European Federation of Clinical Chemistry and Laboratory Medicine

    Fasting sample recommendations for laboratory tests

    EFLM recommendations on fasting and preanalytical standardization.

  15. [15]

    National Institute of Diabetes and Digestive and Kidney Diseases

    The A1C Test & Diabetes

    NIH/NIDDK A1C diagnostic thresholds, confirmation and method considerations.